Connect Sign In
LabMind podcasts
In 2008, Megan Flipse started in ARUP's Exception Handling department in an entry-level role. Now, she oversees multiple departments as a Support Services group manager. |
October 5, 2022 |
From Entry Level to Professional Leadership: How One ARUP Employee Climbed the Career Ladder Group Manager Megan Flipse discusses her start as a laboratory client support technician, the completion of her medical laboratory science degree, and her career advancement at ARUP. |
ARUP Consult®, a free source of laboratory testing information for clinicians, released user experience (UX) upgrades to Consult topic pages and created a new genetics homepage in September. |
October 3, 2022 |
ARUP Consult Updates UX Design and Acute Lymphoblastic Leukemia Topic In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia. |
|
September 26, 2022 |
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe. |
Ryan Metcalf, MD, CQA(ASQ), section chief of Transfusion Medicine at ARUP and University of Utah Health, at ARUP Blood Services, a collection site for an ARUP/University of Utah Health study to determine whether convalescent plasma is an effective treatment for COVID-19. |
September 21, 2022 |
New AABB Guidelines Clarify Efficacious Uses of Convalescent Plasma in Treatment of COVID-19 Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment. |
In her lab at the University of Utah, Allison Carey, MD, PhD, is using a molecular barcoding approach she developed to identify the genes that allow some strains of Mycobacterium avium to establish chronic infections and resist treatment with antibiotics. |
September 16, 2022 |
ARUP Medical Director’s Research Into a Chronic Bacterial Infection Earns a Prestigious NIAID Grant The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research. |
NanoSpot.ai’s agreement with the Greek company Opto enables the commercialization and distribution in Europe of NanoSpot.ai’s line of antibody tests, including the SARS-CoV-2 test pictured here. |
September 14, 2022 |
NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in Europe NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat